Pasithea Therapeutics (KTTA) Non-Current Assets (2021 - 2026)

Pasithea Therapeutics' Non-Current Assets history runs 6 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 57.54% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $23.9 million (down 31.99% YoY), while the FY2025 annual figure was $3.8 million, down 56.52% from the prior year.
• Non-Current Assets came in at $3.6 million for Q1 2026 at Pasithea Therapeutics, down from $3.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $11.1 million in Q4 2022 to a low of $128619.0 in Q1 2022.
• A 5-year average of $7.6 million and a median of $8.7 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 59863.97% in 2022 and sank 57.54% in 2026, its largest moves.
• Pasithea Therapeutics' Non-Current Assets stood at $11.1 million in 2022, then dropped by 15.12% to $9.4 million in 2023, then retreated by 7.73% to $8.7 million in 2024, then plunged by 56.52% to $3.8 million in 2025, then fell by 4.17% to $3.6 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $3.6 million, $3.8 million, and $8.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison